hepatitis B DNA vaccine

**Hepatitis B DNA vaccine** is an Oxxon Therapeutics therapeutic vaccine program for chronic hepatitis B. It is described as a DNA vaccine intended to generate antigen-specific immune responses against hepatitis B virus, consistent with Oxxon's Hi-8 PrimeBoost approach to inducing cellular immune responses. Public pipeline information identifies hepatitis B as the indication and reports Phase 2 development; no INN, marketed brand, plasmid construct identifier, antigen sequence, adjuvant, or commercial formulation has been publicly established for the pipeline entry. ([synapse.patsnap.com](https://synapse.patsnap.com/drug/a20b0cad206f4c6082d013f3ac50732e))